[wpml_language_selector_widget]

FAQs

IH is a disorder of excessive sleep with distinct diagnostic criteria and clinical features. These include excessive daytime sleepiness (EDS), trouble thinking and concentrating, sleep inertia, long unrefreshing naps and long sleep time.

Yes, IH is a real medical condition. However, many caregivers incorrectly think it refers to any case of excessive daytime sleepiness that cannot be explained by another preexisting medical problem or behavior. This is not true though – IH is an actual diagnosis based on several criteria (see “How is IH diagnosed” below). IH is considered a rare disease, with about 1.5% of the population experiencing it.

The word “idiopathic” means the cause is unknown. While the exact cause of IH is not fully understood, certain pathways in the brain may be involved, as well as genetics.

An IH diagnosis can be diagnosed with the following criteria:

  • Daily periods of irrepressible need to sleep or daytime lapses into sleep occurring for at least 3 months
  • No cataplexy (sudden loss of muscle tone while awake, leading to loss of muscle control)
  • Fewer than 2 sleep-onset rapid eye movement periods (SOREMPs) or no SOREMPs if the REM latency on the preceding nocturnal polysomnography was ≤15 minutes
  • PSG and MSLT findings not consistent with narcolepsy type 1 or 2
  • Presence of at least 1 of the following:
    • MSLT shows a mean sleep latency of ≤8 minutes
    • Total 24-hour sleep time is ≥11 hours
  • Findings are not better explained by another sleep disorder, or use of drugs or medications

Excessive daytime sleepiness
Inability to stay awake and alert during the day, leading to periods of intense need for sleep or unintended periods of drowsiness or sleep.

Profound sleep inertia or “sleep drunkenness”
Difficulty waking up; multiple returns to sleep; irritability and confusion upon waking.

Cognitive impairment or “brain fog”
Deficits in attention, difficulty concentrating, and memory loss.

Long unrefreshing naps
When napping during the day, the majority of patients sleep for longer than 60 minutes, though they report that these naps are not refreshing. Many patients with IH refrain from napping for this reason, despite ongoing sleepiness.

Prolonged sleep time
When an individual’s total 24-hour sleep time is at least 11 hours.

Sleep inertia, also called “sleep drunkenness” is very common in patients with IH. It can be described as:

Difficulty waking up in the morning

Feeling caught between sleep and wake states

Lasting minutes to several hours

Feeling confused or uncoordinated

Causing performance impairment and reduced attention

Cardiovascular conditions are common in IH and other sleep disorder and include elevated cholesterol, use of diabetes and obesity medications, high blood pressure, and a history of cardiovascular disease.

The most common non-medication strategies for IH include caffeine, daytime naps, and scheduling of nocturnal sleep. Exercise, dietary changes, temperature changes, chewing gum, mindfulness, and yoga are other methods. Though these may work for some, many patients with IH report these strategies as ineffective.

At this time there is only one treatment approved by the FDA: lower-sodium oxybate. Several other agents may be used off label, including:

  • Bupropion and other alerting antidepressants
  • Clarithromycin
  • Flumazenil
  • Levothyroxine
  • Modafinil/armodafinil
  • Pitolisant
  • Sodium oxybate (regular and extended-release)
  • Solriamfetol
  • Traditional stimulants (eg, amphetamines and methylphenidate)

No. Because the cause of IH is unknown, medications used for IH help manage symptoms, but are not curative.

References

  • Anderson KN, Pilsworth S, Sharples LD, Smith IE, Shneerson JM. Idiopathic hypersomnia: A study of 77 cases. Sleep. 2007;30:1274-1281. doi:10.1093/sleep/30.10.1274
  • Hypersomnolence Australia. Frequently Asked Questions. (https://www.hypersomnolenceaustralia.org.au/single-post/frequently-asked-questions)
  • Plante DT, Hagen EW, Barnet JH, Mignot E, Peppard PE. Prevalence and course of idiopathic hypersomnia in the Wisconsin Sleep Cohort study. Neurology. 2024;102:e207994. doi:10.1212/WNL.0000000000207994
  • Sleep Counts. Idiopathic Hypersomnia (IH) is a multi-symptom sleep disorder. (https://www.sleepcountshcp.com/what-is-idiopathic-hypersomnia/)
  • Vernet C, Arnulf I, Idiopathic hypersomnia with and without long sleep time: A controlled series of 75 patients. Sleep. 2009;32:753-739. doi:10.1093/sleep/32.6.753
  • Voderholzer U, Backhaus J, Hornyak M, Hohagen F, Berger M, Riemann D. A 19-h spontaneous sleep period in idiopathic central nervous system hypersomnia J Sleep Res. 1998;7:101-103. doi:10.1046/j.1365-2869.1998.00108.x

All URLs accessed July 8, 2024

Pin It on Pinterest

Scroll to Top

You are now leaving the THRIVE site

The THRIVE Neuroscience Community of Care site is funded by an independent medical education grant from Jazz Pharmaceuticals. The following site is not affiliated with the THRIVE educational initiative and MLG is not responsible for its content.

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers